{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:08:07Z","timestamp":1791932887714,"version":"4.3.4"},"reference-count":105,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"RISCC Network","award":["847845"],"award-info":[{"award-number":["847845"]}]},{"name":"RISCC Network","award":["P3-00083"],"award-info":[{"award-number":["P3-00083"]}]},{"name":"Slovenian Research Agency","award":["847845"],"award-info":[{"award-number":["847845"]}]},{"name":"Slovenian Research Agency","award":["P3-00083"],"award-info":[{"award-number":["P3-00083"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cervical intraepithelial neoplasia grade 2 (CIN2) is an intermediate stage between CIN 1, which is a low-grade lesion, and CIN3, which is the immediate precursor of cervical cancer (CC). Traditionally, CIN2 was regarded as a high-grade lesion and was treated with conization or ablative methods. In recent years, there has been a shift in the management of younger patients, who are now more often being managed conservatively due to frequent spontaneous CIN2 regression and possible adverse effects of treatment on future pregnancies. Because the risk of progression to CC still exists with conservative management, a personalized approach is needed to identify patients with a higher probability of progression. In this regard, research has focused on the role of host and human papillomavirus (HPV) gene methylation. This systematic review summarizes the current knowledge regarding conservative CIN2 management focusing on the main methylation markers and its implementation in conservative CIN2 management, and it describes major ongoing longitudinal studies on the subject. The review showed that DNA methylation is an accurate predictor of disease progression and a valid triage tool for HPV-positive women, with CIN2 performing better than triage cytology. Because virtually all CCs are methylation-positive, methylation-negative women at baseline have an extremely low risk of CC.<\/jats:p>","DOI":"10.3390\/ijms24076479","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T03:17:35Z","timestamp":1680146255000},"page":"6479","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Role of Methylation of Host and\/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions"],"prefix":"10.3390","volume":"24","author":[{"given":"Andra\u017e","family":"Dovnik","sequence":"first","affiliation":[{"name":"University Clinic for Gynecology and Obstetrics, Maribor University Medical Center, Ljubljanska 5, 2000 Maribor, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-7564","authenticated-orcid":false,"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zalo\u0161ka 4, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/1471-0528.16395","article-title":"The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: A review","volume":"128","author":"Kremer","year":"2021","journal-title":"BJOG"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: Retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"k499","DOI":"10.1136\/bmj.k499","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: Systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.jgyn.2007.11.017","article-title":"Management of CIN1","volume":"37","author":"Rouzier","year":"2008","journal-title":"J. Gynecol. Obstet. Biol. Reprod."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"96.e1","DOI":"10.1016\/j.ajog.2019.12.017","article-title":"A prospective study of treatments for cervical intraepithelial neoplasia and fecundability","volume":"223","author":"Wise","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","article-title":"Diagnoses and outcomes in cervical cancer screening: A population-based study","volume":"191","author":"Insinga","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","unstructured":"Kurman, R.J., Carcangiu, M.L., Herrington, C.S., and Young, R.H. (2014). WHO Classification of Tumours of Female Reproductive Organs, International Agency for Research on Cancer."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.5858\/133.5.729","article-title":"Current concepts in cervical pathology","volume":"133","author":"Park","year":"2009","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","article-title":"The reproducibility of CIN diagnoses among different pathologists: Data from histology reviews from a multicenter randomized study","volume":"132","author":"Collina","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijgo.2014.03.037","article-title":"Reproducibility of cervical intraepithelial neoplasia diagnosis on histological review of cervical punch biopsies from a visual inspection with acetic acid and HPV detection-based screening program","volume":"126","author":"Mittal","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","article-title":"Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia","volume":"133","author":"Bergeron","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/modpathol.2016.168","article-title":"Usefulness of p16INK4a staining for managing histological high-grade squamous intraepithelial cervical lesions","volume":"30","author":"Miralpeix","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/aogs.14459","article-title":"Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population","volume":"101","author":"Ebisch","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/AOG.0000000000000287","article-title":"Treatment of cervical precancers: Back to basics","volume":"123","author":"Khan","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: Meta-analysis","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"g6192","DOI":"10.1136\/bmj.g6192","article-title":"Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: Systematic review and meta-analysis","volume":"349","author":"Kyrgiou","year":"2014","journal-title":"BMJ"},{"key":"ref_19","first-page":"CD008478","article-title":"Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia","volume":"2015","author":"Kyrgiou","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: Systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"ref_21","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1470-2045(22)00334-5","article-title":"Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: A systematic review and network meta-analysis","volume":"23","author":"Athanasiou","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_23","unstructured":"(2022, December 07). LLETZ (Large Loop Excision of the Transformation Zone) Patient Information Leaflet. Available online: https:\/\/www.rcog.org.uk\/globalassets\/documents\/patients\/patient-information-leaflets\/gynaecology\/lletz_jcct-rcog_v1.0_2020.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"ref_25","unstructured":"(2022, December 13). WHO Guidelines: Use of Cryotherapy for Cervical Intraepithelial Neoplasia. Geneva: World Health Organization; 2011, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK138476\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/GMIT.GMIT_56_18","article-title":"Loop electrosurgical excision procedure versus cryotherapy in the treatment of cervical intraepithelial neoplasia: A systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Arduino","year":"2018","journal-title":"Gynecol. Minim. Invasive. Ther."},{"key":"ref_27","first-page":"CD001318","article-title":"Surgery for cervical intraepithelial neoplasia","volume":"12","author":"Paraskevaidis","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1471-0528.16081","article-title":"Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: A cohort study","volume":"127","author":"Skorstengaard","year":"2020","journal-title":"BJOG"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ijgc-2019-000343","article-title":"Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2","volume":"29","author":"Koeneman","year":"2019","journal-title":"Int. J. Gynecol. Cancer."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2018.10.038","article-title":"Justifying conservative management of CIN2 in women younger than 25 years\u2014A population-based study","volume":"152","author":"Loopik","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejogrb.2018.07.018","article-title":"Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study","volume":"228","author":"Godfrey","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/LGT.0000000000000399","article-title":"Outcomes of conservative management of high grade squamous intraepithelial lesions in young women","volume":"22","author":"Lee","year":"2018","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7955290","DOI":"10.1155\/2022\/7955290","article-title":"Comparison of expectant and excisional\/ablative management of cervical intraepithelial neoplasia grade 2 (CIN2) in the era of HPV testing","volume":"2022","author":"Tjandraprawira","year":"2022","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2019.03.023","article-title":"Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience","volume":"236","author":"Hong","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2021.06.019","article-title":"Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping","volume":"162","author":"Miralpeix","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-17-0293","article-title":"Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21\u201339 years","volume":"11","author":"Silver","year":"2018","journal-title":"Cancer Prev. Res."},{"key":"ref_37","first-page":"11","article-title":"Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer","volume":"15","author":"Sen","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13027-016-0107-4","article-title":"Molecular mechanisms of HPV mediated neoplastic progression","volume":"11","author":"Senapati","year":"2016","journal-title":"Infect. Agent. Cancer."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00281-019-00773-0","article-title":"Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle","volume":"42","author":"Burley","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41379-020-0528-x","article-title":"Characterization of cervical biopsies of women with HIV and HPV co-infection using p16ink4a, ki-67 and HPV E4 immunohistochemistry and DNA methylation","volume":"33","author":"Kremer","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/v9090248","article-title":"Epigenetic alterations in human papillomavirus-associated cancers","volume":"9","author":"Soto","year":"2017","journal-title":"Viruses"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3390\/v7052450","article-title":"The role of the DNA damage response throughout the papillomavirus life cycle","volume":"7","author":"McKinney","year":"2015","journal-title":"Viruses"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fgene.2020.00660","article-title":"Accurate detection of HPV integration sites in cervical cancer samples using the Nanopore MinION Sequencer without error correction","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/ijc.29872","article-title":"Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV-related cervical carcinogenesis","volume":"138","author":"Zhang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human Papillomavirus E6 and E7: The cervical cancer hallmarks and targets for therapy","volume":"10","author":"Pal","year":"2020","journal-title":"Front Microbiol"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/15592294.2018.1507197","article-title":"Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer","volume":"13","author":"Verlaat","year":"2018","journal-title":"Epigenetics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/ijc.31549","article-title":"Molecular progression to cervical precancer, epigenetic switch or sequential model?","volume":"143","author":"Nedjai","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.7150\/jca.30081","article-title":"Searching HPV genome for methylation sites involved in molecular progression to cervical precancer","volume":"10","author":"Kottaridi","year":"2019","journal-title":"J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pvr.2016.04.003","article-title":"Molecular events leading to HPV-induced high grade neoplasia","volume":"2","author":"Wilting","year":"2016","journal-title":"Papillomavirus Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Bu, Q., Wang, S., Ma, J., Zhou, X., Hu, G., Deng, H., Sun, X., Hong, X., Wu, H., and Zhang, L. (2018). The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4877-5"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"Berkhof","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: Cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1093\/cid\/ciac433","article-title":"FAM19A4\/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16\/18 Genotyping in HPV-Positive Women Under the Age of 30 Years","volume":"76","author":"Vink","year":"2023","journal-title":"Clin Infect Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ijc.29706","article-title":"CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies","volume":"138","author":"Snijders","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","article-title":"Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer","volume":"135","author":"Verhoef","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijc.30534","article-title":"Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n\u2009 >\u2009 6000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer","volume":"140","author":"Kocsis","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181c7fe6e","article-title":"Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer","volume":"20","author":"Huang","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2021.02.011","article-title":"DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan","volume":"161","author":"Chang","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.7314\/APJCP.2015.16.14.5843","article-title":"Value of PAX1 methylation analysis by MS-HRM in the triage of atypical squamous cells of undetermined significance","volume":"16","author":"Li","year":"2015","journal-title":"Asian. Pac. J. Cancer. Prev."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bee, K.J., Gradissimo, A., Chen, Z., Harari, A., Schiffman, M., Raine-Bennett, T., Castle, P.E., Clarke, M., Wentzensen, N., and Burk, R.D. (2021). Genetic and epigenetic variations of HPV52 in cervical precancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126463"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jnci\/djs425","article-title":"Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3","volume":"104","author":"Wentzensen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcv.2013.12.014","article-title":"A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers","volume":"59","author":"Brentnall","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-17-3251","article-title":"Human papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women","volume":"24","author":"Clarke","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ijc.30008","article-title":"Validation of a DNA methylation HPV triage classifier in a screening sample","volume":"138","author":"Lorincz","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/CBM-150507","article-title":"HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \\textit{EPB41L3} methylation classifier","volume":"15","author":"Brentnall","year":"2015","journal-title":"Cancer Biomark."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13148-019-0743-9","article-title":"Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16\/18 genotyping","volume":"11","author":"Lorincz","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/ijc.31976","article-title":"Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial","volume":"144","author":"Cook","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1476-4598-9-167","article-title":"Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer","volume":"9","author":"Wilting","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_72","first-page":"4448","article-title":"MicroRNA-551b expression profile in low and high-grade cervical intraepithelial neoplasia","volume":"22","author":"Lukic","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_73","first-page":"523","article-title":"MicroRNA expressions in HPV-induced cervical dysplasia and cancer","volume":"35","author":"Gocze","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s12253-020-00852-w","article-title":"Increased miR-20b level in high grade cervical intraepithelial neoplasia","volume":"26","author":"Galamb","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/onc.2012.20","article-title":"Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis","volume":"32","author":"Wilting","year":"2013","journal-title":"Oncogene"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1186\/s40064-016-3524-3","article-title":"Low expression levels of putative HPV encoded microRNAs in cervical samples","volume":"5","author":"Virtanen","year":"2016","journal-title":"Springerplus"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Wang, H., Zhang, D., Chen, Q., and Hong, Y. (2019). Plasma expression of miRNA-21, -\u2009214, -34a, and -200a in patients with persistent HPV infection and cervical lesions. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6066-6"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"dju241","DOI":"10.1093\/jnci\/dju241","article-title":"MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women","volume":"106","author":"Tian","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/15592294.2019.1600390","article-title":"Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease","volume":"14","author":"Babion","year":"2019","journal-title":"Epigenetics"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ye, J., Cheng, X.D., Cheng, B., Cheng, Y.F., Chen, X.J., and Lu, W.G. (2019). MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL\/CIN1 diagnosis after colposcopy-guided biopsy. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5311-3"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Deftereos, G., Corrie, S.R., Feng, Q., Morihara, J., Stern, J., Hawes, S.E., and Kiviat, N.B. (2011). Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028423"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.29824","article-title":"Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)","volume":"138","author":"Luttmer","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/bjc.2016.200","article-title":"FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women","volume":"115","author":"Luttmer","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"Meijer","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.31787","article-title":"Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population","volume":"144","author":"Leeman","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ijc.33566","article-title":"Classification of high-grade cervical intraepithelial neoplasia by p16ink4a, Ki-67, HPV E4 and FAM19A4\/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management","volume":"149","author":"Vink","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"831949","DOI":"10.3389\/fonc.2022.831949","article-title":"Detection of host cell gene\/HPV DNA methylation markers: A promising triage approach for cervical cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.2367","article-title":"Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC","volume":"215","author":"Overmeer","year":"2008","journal-title":"J. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Dankai, W., Khunamornpong, S., Siriaunkgul, S., Soongkhaw, A., Janpanao, A., Utaipat, U., Kitkumthorn, N., Mutirangura, A., Srisomboon, J., and Lekawanvijit, S. (2019). Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210289"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2598","article-title":"Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis","volume":"219","author":"Overmeer","year":"2009","journal-title":"J. Pathol."},{"key":"ref_91","first-page":"7166","article-title":"Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia","volume":"16","author":"Kalman","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2018.08.031","article-title":"Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women","volume":"151","author":"Fiano","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Del Pino, M., Sierra, A., Marimon, L., Mart\u00ed Delgado, C., Rodriguez-Trujillo, A., Barnadas, E., Saco, A., Torn\u00e9, A., and Ordi, J. (2019). CADM1, MAL, and miR124 promoter methylation as biomarkers of transforming cervical intrapithelial lesions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092262"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jclinpath-2014-202616","article-title":"CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer","volume":"67","author":"Steenbergen","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41379-018-0101-z","article-title":"HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions","volume":"31","author":"Zummeren","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ijc.28723","article-title":"Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy","volume":"135","author":"Hesselink","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13148-015-0122-0","article-title":"Triage of high-risk human papillomavirus-positive women by methylated POU4F3","volume":"7","author":"Pun","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","article-title":"Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women","volume":"9","author":"Schmitz","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Schmitz, M., Eichelkraut, K., Schmidt, D., Zeiser, I., Hilal, Z., Tettenborn, Z., Hansel, A., and Ikenberg, H. (2018). Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-5125-8"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_101","first-page":"2278","article-title":"Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions","volume":"15","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","article-title":"Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): A systematic review and meta-analysis","volume":"121","author":"Kelly","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1200\/JCO.21.02433","article-title":"Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124-2 DNA methylation (CONCERVE study)","volume":"40","author":"Kremer","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/01443615.2017.1316973","article-title":"Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members\u2019 opinion","volume":"38","author":"Macdonald","year":"2018","journal-title":"J. Obstet. Gynaecol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6479\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:06:52Z","timestamp":1760123212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076479"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076479","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}